Dark Streaming/Mobile Old Site Home Daily Products Help Contact Us Your Account System Status
Sign-up for a FREE 30-day Stockwatch subscription and SEE NO ADS
14:44:45 EDT Fri 24 Mar 2023
Enter Symbol
or Name
USA
CA



News for U:IBIO from 2022-03-25 to 2023-03-24 - 17 items News ReleasesIn The NewsOther CAUS
DateSymPriceTypeHeadline
2023-02-16 16:48U:IBIONews ReleaseiBio Announces MUC16 as its Latest Immune-Oncology Target Program
2023-01-05 08:00U:IBIONews ReleaseiBio Announces Issuance of U.S. Patent Covering AI-Engineered Epitope Discovery Engine
2022-12-09 16:05U:IBIONews ReleaseiBio Announces Closing of $3.5 Million Underwritten Public Offering
2022-12-06 23:28U:IBIONews ReleaseiBio Announces Pricing of $3.5 Million Underwritten Public Offering
2022-12-06 16:01U:IBIONews ReleaseiBio Announces Proposed Underwritten Public Offering
2022-12-06 08:00U:IBIONews ReleaseiBio to Participate in the JMP Securities Hematology and Oncology Summit
2022-12-05 08:00U:IBIONews ReleaseiBio ‚ ® to Showcase the RubrYc ‚ ® Discovery Engine During Poster Presentations at Antibody Engineering & Therapeutics Conference 2022
2022-12-02 16:30U:IBIONews ReleaseiBio Announces CEO Departure
2022-11-03 08:00U:IBIONews ReleaseiBio Accelerates Transformation to AI-Powered Biotech
2022-09-27 16:10U:IBIONews ReleaseiBio Reports Preliminary Unaudited Fiscal Year 2022 Financial Results and Provides Corporate Update
2022-09-21 08:30U:IBIONews ReleaseiBio Acquires RubrYc Therapeutics' AI Drug Discovery Platform and Pipeline
2022-08-16 09:00U:IBIONews ReleaseiBio Provides Update on Development of Next-Gen COVID-19 Vaccine Candidate
2022-05-18 08:00U:IBIONews ReleaseiBio to Participate in the H.C. Wainwright Global Investment Conference
2022-05-12 16:05U:IBIONews ReleaseiBio Reports Fiscal Third Quarter 2022 Financial Results and Provides Corporate Update
2022-05-09 08:00U:IBIONews ReleaseiBio Demonstrates Efficacy of an IL-2 Sparing Anti-CD25 Antibody Produced Using its FastPharming System for Treg Depletion in Cancer
2022-05-05 16:30U:IBIONews ReleaseiBio to Report Fiscal 2022 Third Quarter Financial Results and Provide Corporate Update on Thursday, May 12, 2022
2022-05-02 08:00U:IBIONews ReleaseiBio Announces Presentation Highlighting Superior Glycosylation for Antibodies Produced in Plants